Disease Burden of Relapsing-Remitting Multiple Sclerosis
Oncology Care Pathways Supporting the Use of High-value Treatments for NSCLC
Implementing the 2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: SGLT2 Inhibitors, Treatment Sequencing, and Value Statements
Uptake of Oncology Biosimilars: Managed Care Strategies to Improve Value-Based Care Systems
Volume: 28
Issue: 5
Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access
Issue: 4
The Role of Real-World Evidence, Patient-Reported Outcomes, and Economic Models in Oncology Formulary Decisions and the Role of Real-World Evidence in Oncology Product Registration
Management of Interstitial Lung Disease: Emerging Therapies and Unmet Needs
Role of Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma
ZEPOSIA® (ozanimod), a Sphingosine 1-Phosphate Receptor Modulator for Relapsing Forms of Multiple Sclerosis
Clinical Trial Data Can Be Supplemented by Real-World Evidence: An Example for an Oral Anticoagulant in Patients With Nonvalvular Atrial Fibrillation at Risk of Stroke
Real-World Evidence Associated With a First-Generation BTK Inhibitor in Patients With CLL/SLL
A Personalized Approach to Disease Management in Psoriasis
From Evidence to Implementation: Clarifications Around the US Preventive Services Task Force Recommendations for HIV Pre-Exposure Prophylaxis
Advancing the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema With Novel and Emerging Monoclonal Antibody Therapy
Issue: 3
Current Landscape of Treatment Options for Patients With Amyotrophic Lateral Sclerosis (ALS)
A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Optimizing Outcomes in Multiple Sclerosis Through Individualized Treatment: Managed Care Considerations
Exclusive Coverage of the 63rd American Society of Hematology Meeting & Exposition
Population Health Guide to the Evolution of Endpoints in Multiple Sclerosis
The Underrecognized Burden of Atopic Dermatitis in the United States
Evaluating the Management of Cancer Immunotherapy (CIT): Roundtable Discussion
Management of TRK Fusion Cancer: Evaluating Targeted Therapies
Issue: 2
Addressing the Individualized Needs in Hereditary Angioedema: Managed Care Strategies to Optimize Access to Care
Issue: 1
Exclusive Coverage of the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting
Implications of Oral Therapy in Metastatic Breast Cancer: Considerations for Delivery Networks
Exclusive Coverage of the Academy of Managed Care Pharmacy Nexus 2021 Meeting
The Effect of Evolving Treatment Options on the Management of Multiple Myeloma
The Evolving Role of Immunotherapies in the Treatment of Cervical Cancer
Patients With Diabetes and Chronic Kidney Disease: ACE Inhibitor or ARB Treatment, Medical Costs for Disease Management, and the FINE-CKD Model to Evaluate Economic Value of Finerenone
Volume: 27
Issue: 20
Examining Developments in Multicancer Early Detection: Highlights of New Clinical Data from Recent Conferences
Issue: 19
